Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Navidea Biopharmaceuticals Inc banner

Navidea Biopharmaceuticals Inc
F:NO1A

Watchlist Manager
Navidea Biopharmaceuticals Inc Logo
Navidea Biopharmaceuticals Inc
F:NO1A
Watchlist
Price: 0.046 EUR Market Closed
Market Cap: €4.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

NO1A Price Targets Summary
Navidea Biopharmaceuticals Inc

There are no price targets for NO1A.
NO1A Lowest Forecast
Wall Street Target
Not Available
NO1A Average Forecast
Wall Street Target
Not Available
NO1A Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Navidea Biopharmaceuticals Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
26% Upside
PRQR
ProQR Therapeutics NV
606% Upside
SSRM
SSR Mining Inc
8% Upside
CFFN
Capitol Federal Financial Inc
5% Upside
PTGX
Protagonist Therapeutics Inc
26% Upside
PRQR
ProQR Therapeutics NV
606% Upside
SSRM
SSR Mining Inc
8% Upside
CFFN
Capitol Federal Financial Inc
5% Upside

Revenue
Forecast

-43% / Year
Past Growth
261% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-43% / Year
Past Growth
261% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss

What are analyst estimates?

See Also

Summary
NO1A intrinsic value, competitors valuation, and company profile.
DCF Valuation
NO1A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NO1A stock valuation using valuation multiples.
Wall Street Estimates
NO1A price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NO1A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NO1A's stock price target?
Not Available

NO1A doesn't have any price targets made by Wall Street professionals.

What is Navidea Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
261%

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.